Logo
x

Search

Subscribe Now

Sign

Sanofi Out Licenses Two Sickle Cell Disease Programs to GBT for $353M

Sanofi Out Licenses Two Sickle Cell Disease Programs to GBT for $353M

  • March 17, 2021
Skyhawk Collaborates with Vertex to Discover and Develop Novel Small Molecules Modulating RNA Splicing for Serious Diseases

Skyhawk Collaborates with Vertex to Discover and Develop Novel Small Molecules Modulating RNA Splicing for Serious Diseases

  • December 30, 2020
Aurobindo Pharma Sign Agreement with COVAXX to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF

Aurobindo Pharma Sign Agreement with COVAXX to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF

  • December 28, 2020
Chugai In-Licenses Roche's Antibody Cocktail for COVID-19 in Japan

Chugai In-Licenses Roche's Antibody Cocktail for COVID-19 in Japan

  • December 11, 2020
AbbVie Collaborates with Frontier Medicines to Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets

AbbVie Collaborates with Frontier Medicines to Develop Novel Therapies and E3 Degraders Against Difficult-to-Drug Targets

  • December 3, 2020
Kaia Health Allied with Chiesi Group to Commercialize COPD App in Europe

Kaia Health Allied with Chiesi Group to Commercialize COPD App in Europe

  • December 1, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.